GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Beneish M-Score

Benevolent AI (XAMS:BAI) Beneish M-Score : 0.06 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 0.06 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Benevolent AI's Beneish M-Score or its related term are showing as below:

XAMS:BAI' s Beneish M-Score Range Over the Past 10 Years
Min: -6.88   Med: -3.37   Max: 0.06
Current: 0.06

During the past 6 years, the highest Beneish M-Score of Benevolent AI was 0.06. The lowest was -6.88. And the median was -3.37.


Benevolent AI Beneish M-Score Historical Data

The historical data trend for Benevolent AI's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Beneish M-Score Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -3.07 -6.88 -3.66 0.06

Benevolent AI Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only -6.88 - -3.66 - 0.06

Competitive Comparison of Benevolent AI's Beneish M-Score

For the Biotechnology subindustry, Benevolent AI's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benevolent AI's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Beneish M-Score falls into.



Benevolent AI Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Benevolent AI for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 4.2285+0.528 * 1+0.404 * 1.5118+0.892 * 0.7009+0.115 * 0.8982
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0092+4.679 * -0.050015-0.327 * 1.3834
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €3.02 Mil.
Revenue was €8.51 Mil.
Gross Profit was €8.51 Mil.
Total Current Assets was €106.08 Mil.
Total Assets was €143.74 Mil.
Property, Plant and Equipment(Net PPE) was €7.99 Mil.
Depreciation, Depletion and Amortization(DDA) was €3.34 Mil.
Selling, General, & Admin. Expense(SGA) was €26.01 Mil.
Total Current Liabilities was €29.06 Mil.
Long-Term Debt & Capital Lease Obligation was €4.44 Mil.
Net Income was €-73.50 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €-66.31 Mil.
Total Receivables was €1.02 Mil.
Revenue was €12.14 Mil.
Gross Profit was €12.14 Mil.
Total Current Assets was €174.87 Mil.
Total Assets was €213.81 Mil.
Property, Plant and Equipment(Net PPE) was €9.75 Mil.
Depreciation, Depletion and Amortization(DDA) was €3.51 Mil.
Selling, General, & Admin. Expense(SGA) was €36.78 Mil.
Total Current Liabilities was €29.48 Mil.
Long-Term Debt & Capital Lease Obligation was €6.54 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.017 / 8.51) / (1.018 / 12.142)
=0.354524 / 0.083841
=4.2285

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(12.142 / 12.142) / (8.51 / 8.51)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (106.079 + 7.988) / 143.738) / (1 - (174.87 + 9.746) / 213.811)
=0.206424 / 0.136546
=1.5118

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=8.51 / 12.142
=0.7009

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3.514 / (3.514 + 9.746)) / (3.343 / (3.343 + 7.988))
=0.265008 / 0.295031
=0.8982

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(26.013 / 8.51) / (36.778 / 12.142)
=3.056757 / 3.02899
=1.0092

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4.438 + 29.062) / 143.738) / ((6.54 + 29.48) / 213.811)
=0.233063 / 0.168467
=1.3834

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-73.496 - 0 - -66.307) / 143.738
=-0.050015

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Benevolent AI has a M-score of 0.06 signals that the company is likely to be a manipulator.


Benevolent AI Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI (XAMS:BAI) Business Description

Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI (XAMS:BAI) Headlines

No Headlines